Extended Genotyping as Triage of HPV Positive Screened Women in Low-and-Middle Income Countries.
Frederick H van der Merwe, Greta Dreyer, Cathy Visser...
https://pubmed.ncbi.nlm.nih.gov/42171389/Actively Recruiting
Led by University of Pretoria · Updated on 2026-07-07
1500
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate new generation HPV DNA-based screening tests for cervical pre-cancer and cancer prevention among South African women, including those who are HIV-positive and HIV-negative. The study addresses the high incidence and mortality rate of cervical cancer in South Africa, especially among women with low cytology screening frequency and high HIV prevalence. The goal is to demonstrate the feasibility and effectiveness of HPV testing followed by cytology and immunocytochemistry as a screening model in this population. Participants will undergo cervical specimen collection using a speculum examination and cervical collection brush. Those with abnormal results may then have a colposcopy involving vaginal speculum examination, application of acetic acid and iodine, and biopsies of abnormal areas. If needed, treatment includes a large loop excision LLETZ performed under local anesthesia. The study groups include women who are HIV-positive, HIV-negative, or with unknown HIV status. During the study, participants cervical health will be assessed through HPV DNA analysis with partial genotyping, cytology, immunocytochemistry, and histological biopsy at colposcopy. The main outcome is the detection of cervical intraepithelial neoplasia grade 2 or higher CIN2. Results will help evaluate the screening tests performance and inform national prevention programs. Participants will be informed of their results by text or clinic visit, and their safety and ability to undergo treatment if needed will be monitored throughout the study.
CONDITIONS
Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
G
Greta Dreyer, PhD
C
Cathy Visser, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pretoria
Lead Sponsor
University of Stellenbosch
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single visit
Participants undergo cervical specimen collection using a speculum examination and cervical collection brush for HPV DNA testing.
1 visit (in-person)
Duration - As needed after screening
Participants with abnormal screening results undergo colposcopy with application of acetic acid and iodine, and punch biopsies of abnormal areas.
1 to 2 visits depending on findings
Duration - Single procedure
If indicated, participants receive large loop excision of abnormal cervical tissue under local anesthesia.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Frederick H van der Merwe, Greta Dreyer, Cathy Visser...
https://pubmed.ncbi.nlm.nih.gov/42171389/Leon Cornelius Snyman, Karin Louise Richter, Azwidowi Lukhwareni...
https://pubmed.ncbi.nlm.nih.gov/36650011/University of Pretoria
Lead Sponsor
University of Stellenbosch
Collaborating Sponsor